Even after countless researches and experiments carried out before its commercialization, it is still possible that the drugs cause unexpected effects in its users. In order to prevent these problems from becoming recurrent, the ideal is that the evaluation of the product is carried out not only by the health agency, but also by the patient himself.
Problems such as intoxication, misuse, excessive medication, administration errors, among other actions, often cause unwanted effects to the user. When using the medication correctly, following the specialist’s guidelines and respecting the indications of the product, the adverse effects will rarely be felt. But, unfortunately they can still happen.
Often rare or severe reactions can appear in certain groups of patients, even after carrying out several tests in the laboratory, so it is more appropriate that the surveillance of drugs is not done only by health agencies.
How does it work?
Also known as pharmacovigilance, this inspection is usually performed by state and municipal health surveillance agencies, and by ANVISA to detect any problems with users involving medications.
From the identification of the product and filling out a notification form, it is possible to contribute to this monitoring. The form must be delivered to the Health Surveillance of your city or sent to ANVISA ([email protected]).
This action is an important tool, as it can help several patients and assist in the prevention of numerous complications through the continuous evaluation of drugs available on the market.
